# E-DRUG: New Drug Classes on Formularies **URL:** \ **Category:** e-drug\ **Created:** [November 7, 1999, 8:34pm UTC](https://talk.edrugplus.org/t/e-drug-new-drug-classes-on-formularies/6544 "1999-11-07T20:34:56Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![J\_Niels\_Rosenquist](https://avatars.discourse-cdn.com/v4/letter/j/7ea924/32.png) [@J\_Niels\_Rosenquist](https://talk.edrugplus.org/u/J_Niels_Rosenquist)\ **Post date:** [November 7, 1999, 8:34pm UTC](https://talk.edrugplus.org/t/e-drug-new-drug-classes-on-formularies/6544/1 "1999-11-07T20:34:56Z")
E-drug: New Drug Classes on Formularies --------------------------------------------- E-druggers, I am trying to learn about new drugs and how national formularies go about evaluating them. I am interested in how long it takes new classes of drugs (ie-COX-2 inhibitors) to get on such formularies and the criteria used in the approval process. Do national formularies generally wait until the drugs go off patent to approve the compound? How is price taken into consideration? I am interested in any countries you may know about as well as at the WHO level. Thanks. Niels Rosenquist MD/PhD Candidate University of Pennsylvania Medical School Wharton School of Business USA "J. Niels Rosenquist" \ -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.